Differentiation between non-hypervascular pancreatic neuroendocrine tumour and pancreatic ductal adenocarcinoma on dynamic computed tomography and non-enhanced magnetic resonance imaging

2019
journal article
article
6
cris.lastimport.wos2024-04-09T23:34:00Z
dc.abstract.enPurpose: To determine the differentiating features between non-hypervascular pancreatic neuroendocrine tumour (PNET) and pancreatic ductal adenocarcinoma (PDAC) on dynamic computed tomography (CT) and non-enhanced magnetic resonance imaging (MRI). Material and methods: We enrolled 102 patients with non-hypervascular PNET (n = 15) or PDAC (n = 87), who had undergone dynamic CT and non-enhanced MRI. One radiologist evaluated all images, and the results were subjected to univariate and multivariate analyses. To investigate reproducibility, a second radiologist re-evaluated features that were significantly different between PNET and PDAC on multivariate analysis. Results: Tumour margin (well-defined or ill-defined) and enhancement ratio of tumour (ERT) showed significant differences in univariate and multivariate analyses. Multivariate analysis revealed a predominance of well-defined tumour margins in non-hypervascular PNET, with an odds ratio of 168.86 (95% confidence interval [CI]: 10.62-2685.29; p < 0.001). Furthermore, ERT was significantly lower in non-hypervascular PNET than in PDAC, with an odds ratio of 85.80 (95% CI: 2.57-2860.95; p = 0.01). Sensitivity, specificity, and accuracy were 86.7%, 96.6%, and 95.1%, respectively, when the tumour margin was used as the criteria. The values for ERT were 66.7%, 98.9%, and 94.1%, respectively. In reproducibility tests, both tumour margin and ERT showed substantial agreement (margin of tumour, κ = 0.6356; ERT, intraclass correlation coefficients (ICC) = 0.6155). Conclusions: Non-hypervascular PNET showed well-defined margins and lower ERT compared to PDAC, with significant differences. Our results showed that non-hypervascular PNET can be differentiated from PDAC via dynamic CT and non-enhanced MRI.pl
dc.contributor.authorOhki, Kazuyoshipl
dc.contributor.authorIgarashi, Takaopl
dc.contributor.authorAshida, Hirokazupl
dc.contributor.authorShiraishi, Megumipl
dc.contributor.authorNozawa, Yosukepl
dc.contributor.authorOjiri, Hiroyapl
dc.date.accessioned2019-04-25T10:00:04Z
dc.date.available2019-04-25T10:00:04Z
dc.date.issued2019pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.additionalBibliogr. s. e160-e161pl
dc.description.physicale153-e161pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume84pl
dc.identifier.doi10.5114/pjr.2019.84193pl
dc.identifier.eissn1899-0967pl
dc.identifier.issn1733-134Xpl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/73727
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa*
dc.rights.licenceCC-BY-NC-ND
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subject.enmagnetic resonance imagingpl
dc.subject.entomographypl
dc.subject.enX-ray computedpl
dc.subject.enpancreatic neoplasmspl
dc.subject.encarcinomapl
dc.subject.enpancreatic ductalpl
dc.subject.enneuroendocrine tumourspl
dc.subject.enadenomapl
dc.subject.enislet cellpl
dc.subtypeArticlepl
dc.titleDifferentiation between non-hypervascular pancreatic neuroendocrine tumour and pancreatic ductal adenocarcinoma on dynamic computed tomography and non-enhanced magnetic resonance imagingpl
dc.title.journalPolish Journal of Radiologypl
dc.typeJournalArticlepl
dspace.entity.typePublication
cris.lastimport.wos
2024-04-09T23:34:00Z
dc.abstract.enpl
Purpose: To determine the differentiating features between non-hypervascular pancreatic neuroendocrine tumour (PNET) and pancreatic ductal adenocarcinoma (PDAC) on dynamic computed tomography (CT) and non-enhanced magnetic resonance imaging (MRI). Material and methods: We enrolled 102 patients with non-hypervascular PNET (n = 15) or PDAC (n = 87), who had undergone dynamic CT and non-enhanced MRI. One radiologist evaluated all images, and the results were subjected to univariate and multivariate analyses. To investigate reproducibility, a second radiologist re-evaluated features that were significantly different between PNET and PDAC on multivariate analysis. Results: Tumour margin (well-defined or ill-defined) and enhancement ratio of tumour (ERT) showed significant differences in univariate and multivariate analyses. Multivariate analysis revealed a predominance of well-defined tumour margins in non-hypervascular PNET, with an odds ratio of 168.86 (95% confidence interval [CI]: 10.62-2685.29; p < 0.001). Furthermore, ERT was significantly lower in non-hypervascular PNET than in PDAC, with an odds ratio of 85.80 (95% CI: 2.57-2860.95; p = 0.01). Sensitivity, specificity, and accuracy were 86.7%, 96.6%, and 95.1%, respectively, when the tumour margin was used as the criteria. The values for ERT were 66.7%, 98.9%, and 94.1%, respectively. In reproducibility tests, both tumour margin and ERT showed substantial agreement (margin of tumour, κ = 0.6356; ERT, intraclass correlation coefficients (ICC) = 0.6155). Conclusions: Non-hypervascular PNET showed well-defined margins and lower ERT compared to PDAC, with significant differences. Our results showed that non-hypervascular PNET can be differentiated from PDAC via dynamic CT and non-enhanced MRI.
dc.contributor.authorpl
Ohki, Kazuyoshi
dc.contributor.authorpl
Igarashi, Takao
dc.contributor.authorpl
Ashida, Hirokazu
dc.contributor.authorpl
Shiraishi, Megumi
dc.contributor.authorpl
Nozawa, Yosuke
dc.contributor.authorpl
Ojiri, Hiroya
dc.date.accessioned
2019-04-25T10:00:04Z
dc.date.available
2019-04-25T10:00:04Z
dc.date.issuedpl
2019
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.additionalpl
Bibliogr. s. e160-e161
dc.description.physicalpl
e153-e161
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
84
dc.identifier.doipl
10.5114/pjr.2019.84193
dc.identifier.eissnpl
1899-0967
dc.identifier.issnpl
1733-134X
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/73727
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa
dc.rights.licence
CC-BY-NC-ND
dc.rights.uri*
http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl
dc.share.type
otwarte czasopismo
dc.subject.enpl
magnetic resonance imaging
dc.subject.enpl
tomography
dc.subject.enpl
X-ray computed
dc.subject.enpl
pancreatic neoplasms
dc.subject.enpl
carcinoma
dc.subject.enpl
pancreatic ductal
dc.subject.enpl
neuroendocrine tumours
dc.subject.enpl
adenoma
dc.subject.enpl
islet cell
dc.subtypepl
Article
dc.titlepl
Differentiation between non-hypervascular pancreatic neuroendocrine tumour and pancreatic ductal adenocarcinoma on dynamic computed tomography and non-enhanced magnetic resonance imaging
dc.title.journalpl
Polish Journal of Radiology
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
6
Views per month
Views per city
Hong Kong
4
Ashburn
2
Downloads
ohki_igarashi_ashida_shiraishi_nozawa_ojiri_differentiation_between_non-hypervascular_pancreatic_neuroendocrine_tumour_2019.odt
439
ohki_igarashi_ashida_shiraishi_nozawa_ojiri_differentiation_between_non-hypervascular_pancreatic_neuroendocrine_tumour_2019.pdf
32